Erratum: Treatment for Preventing Tuberculosis in Children and Adolescents : Ed Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid (JAMA Pediatrics (2015) 169:3 (247-255))

Fingerprint

Dive into the research topics of 'Erratum: Treatment for Preventing Tuberculosis in Children and Adolescents : Ed Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid (JAMA Pediatrics (2015) 169:3 (247-255))'. Together they form a unique fingerprint.